Previous studies indicate that NRF2 activation induces cytoplasmic IDH1 and ME1, highlighting their role in maintaining the NADPH pool in NRF2 hyperactivated NSCLC cells [19,23]. The gene discussed is IDH1; the disease is non-small cell lung carcinoma.